Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 151 entries
View as:

Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate

Phase: N/A Priority: Normal
NCT ID: NCT01080716 Org: User:
Start: 05/31/10 End: 12/31/11 Due: 12/31/12

A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents

Phase: N/A Priority: Normal
NCT ID: NCT01843491 Org: User:
Start: 06/30/13 End: 06/30/14 Due: 06/30/15

HIV Vaccine Trial in Thai Adults

Phase: N/A Priority: Normal
NCT ID: NCT00223080 Org: User:
Start: 10/31/03 End: 06/30/09 Due: 06/30/10

Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application

Phase: N/A Priority: Normal
NCT ID: NCT00490230 Org: User:
Start: 04/30/07 End: 06/30/07 Due: 06/30/08

Study of Immune Responses Induced by a HIV Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01933685 Org: User:
Start: 07/03/14 End: 05/31/20 Due: 05/31/21

A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand

Phase: N/A Priority: Normal
NCT ID: NCT00370682 Org: User:
Start: 04/30/07 End: 02/29/08 Due: 02/28/09

Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05423418 Org: User:
Start: 08/29/22 End: 10/23/28 Due: 10/23/29

An Evaluation of Weekly Tafenoquine

Phase: N/A Priority: Normal
NCT ID: NCT02488980 Org: User:
Start: 05/31/00 End: 03/31/03 Due: 03/31/04

Ascending Doses of Autologous FDP vs FFP

Phase: N/A Priority: Normal
NCT ID: NCT02930226 Org: User:
Start: 02/13/17 End: 08/02/18 Due: 08/02/19

Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection

Phase: N/A Priority: Normal
NCT ID: NCT00761020 Org: User:
Start: 09/30/08 End: 12/31/09 Due: 12/31/10

Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02654509 Org: User:
Start: 06/03/08 End: 03/18/18 Due: 03/18/19

Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Full Trial)

Phase: N/A Priority: Normal
NCT ID: NCT02125591 Org: User:
Start: 08/31/15 End: 12/31/16 Due: 12/31/17

Western Equine Encephalitis Vaccine, Inactivated

Phase: N/A Priority: Normal
NCT ID: NCT01159561 Org: User:
Start: 02/28/10 End: 03/31/12 Due: 03/31/13

Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)

Phase: N/A Priority: Normal
NCT ID: NCT01032382 Org: User:
Start: 01/31/10 End: 07/31/11 Due: 07/31/12

Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01290601 Org: User:
Start: 09/15/03 End: 01/10/05 Due: 01/10/06

Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America

Phase: N/A Priority: Normal
NCT ID: NCT00312663 Org: User:
Start: 04/30/06 End: 04/30/07 Due: 04/30/08

Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial

Phase: N/A Priority: Normal
NCT ID: NCT00337181 Org: User:
Start: 05/31/06 End: 06/30/11 Due: 06/30/12

An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample

Phase: N/A Priority: Normal
NCT ID: NCT04180930 Org: User:
Start: 04/15/19 End: 06/30/25 Due: 06/30/26

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00376090 Org: User:
Start: 07/31/05 End: 12/31/08 Due: 12/31/09

A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04296279 Org: User:
Start: 03/20/20 End: 12/31/22 Due: 12/31/23

Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00582504 Org: User:
Start: 09/30/07 End: 06/30/22 Due: 06/30/23

Study of the Safety of Intravenous Artesunate

Phase: N/A Priority: Normal
NCT ID: NCT00292929 Org: User:
Start: - End: 10/31/06 Due: 10/31/07

Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B

Phase: N/A Priority: Normal
NCT ID: NCT02458092 Org: User:
Start: 04/30/08 End: 06/30/09 Due: 06/30/10

A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01666652 Org: User:
Start: 09/30/12 End: 11/30/17 Due: 11/30/18

Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR)

Phase: N/A Priority: Normal
NCT ID: NCT02445963 Org: User:
Start: 10/01/15 End: 05/13/16 Due: 05/13/17